The SARS-CoV-2 sero-positivity rate among children is high and comparable to the adult population and hence, it is unlikely that any future third wave of the prevailing COVID-19 variant would disproportionately affect children aged two years and above, according to the interim findings of an
A 65-year-old woman has tested positive for the new ‘Delta Plus’ variant of coronavirus here, official sources said on Thursday.
The development came even as the second wave of the pandemic is waning in Madhya Pradesh and restrictions imposed to prevent the spread of the infection
Pregnant and postpartum women were more severely affected during the second wave of COVID-19 as compared to the first with symptomatic cases and the case fatality rate being significantly higher among this category this year, according to a study by ICMR.
The Indian Council of Medical
Dr Reddy’s Laboratories which has soft-launched Russia’s COVID-19 vaccine Sputnik V here has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi.
Presently it being a limited pilot phase, registration on CoWIN is not open for
The government has allowed setting up of ‘near home’ vaccination centres for elderly and differently-abled people for simplifying the process of inoculation for them.
In a statement, Minister of State for Social Justice and Empowerment Rattan Lal Kataria highlighted various steps taken by the government to
With close gathering of shoppers in markets and restaurants resuming business amid phased unlock in the national capital, doctors on Tuesday cautioned that Delhi could face a “worse than second wave situation” of COVID-19 if people do not adhere to safety norms or lower their
Dismissing assumptions that children and the younger population were more affected in the second wave of Covid, the government on Tuesday said those in the 1-20 age group accounted for less than 12 per cent of the cases recorded during both the waves.
Those aged 1-20
The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday.
There was no dissenting voice among the members of the National Technical Advisory Group on Immunization (NTAGI
The recruitment for the clinical trial of the country’s first indigenously-developed COVID-19 vaccine, Covaxin, among children in the age group of 6-12 years will begin at the AIIMS here from Tuesday.
This will be followed by the clinical trial of children in the age-group of 2-6
A decrease in the number of Covid cases should never inculcate a sense of complacency among the public, Union Health Minister Harsh Vardhan said on Friday, underlining that the behavioural pattern of putting masks on and off intermittently, improper wearing of masks and not following